Foralumab (NI-0401) is a potent, orally active humanized monoclonal antibody targeting the
[1]. Ogura M, et, al. Oral treatment with foralumab, a fully human anti-CD3 monoclonal antibody, prevents skin xenograft rejection in humanized mice. Clin Immunol. 2017 Oct;183:240-246.
















